Ensysce Biosciences, Inc. (ENSC) Net margin 2020–2025
Ensysce Biosciences, Inc. (ENSC) net profit margin by fiscal year — reported net income divided by reported revenue.
-200.8%FY2025 · since FY2020: 109.7% → -200.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -200.8% | -47.5 pp |
| FY2024 | -153.3% | +323.1 pp |
| FY2023 | -476.4% | +482.9 pp |
| FY2022 | -959.3% | -134.0 pp |
| FY2021 | -825.4% | -935.0 pp |
| FY2020 | 109.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ENSC financial trends
ENSC RevenueENSC Net incomeENSC Gross profitENSC Gross marginENSC Operating incomeENSC Operating marginENSC Operating cash flowENSC Free cash flowENSC Capital expendituresENSC Return on equityENSC Stock buybacksENSC Dividends paidENSC Total assetsENSC Total liabilitiesENSC Shareholders’ equityENSC overview →